" /> CDK2 Inhibitor INX-315 - CISMeF





Preferred Label : CDK2 Inhibitor INX-315;

NCIt related terms : INX-315;

NCIt definition : An orally bioavailable small molecule inhibitor of cyclin-dependent kinase 2 (CDK2), with potential antineoplastic activity. Upon oral administration, CDK2 inhibitor INX-315 selectively targets, binds to and inhibits the activity of CDK2. This may lead to cell cycle arrest, the induction of apoptosis, and the inhibition of tumor cell proliferation. CDKs are serine/threonine kinases that are important regulators of cell cycle progression and cellular proliferation and are frequently overexpressed in tumor cells.;

UNII : 2QD8YT8RWZ;

CAS number : 2745060-92-6;

Molecule name : INX-315; INX 315;

NCI Metathesaurus CUI : CL1907326;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.